|Day Low/High||17.30 / 17.87|
|52 Wk Low/High||8.86 / 32.48|
The company's size and scale are nearly unmatched in its sector.
Before we get to the seasonal Christmas-New Year's slowdown that's ahead of us, there will be several earnings reports worth digging into next week. I suspect FedEx's guidance will help set the holiday spending mood, while Darden's comments will lik...
As Pimm Fox on Bloomberg Radio would say, good morning, good morning! With Doug out today, I'll be once again taking the Diary wheel for a spin. U.S. equities tumbled on Wednesday as the surge in reported coronavirus cases put the kybosh on the re-o...
RAD seems to be off everyone's radar and that makes it more interesting to me.
With so many consumers preparing for a potential coronavirus outbreak, you might think that owning retail pharmacy stocks makes sense right now.
Wrong valuations -- such as those in Conagra Brands and Rite Aid -- exist, and they can make you money.
Sellers of the drugstore chain's stock have been aggressive for months and the overall technical picture is weak.
The contagion in pharmacy stocks is spreading and secular trends aren't helping to find a solution anytime soon.
Walgreens weak guidance is sending shares plummeting on Tuesday.
CNBC is reporting that Kroger and Walgreens Boots Alliance are "exploring a partnership to offer customers a new service that allows them to pick up groceries ordered online at Kroger at certain Walgreens locations..." Yes this signals that more ch...
Rite Aid CEO John Standley faces shareholders's scrutiny after the merger flop.
After a failed merger with Albertsons, Rite Aid faces a difficult time on its own in a changing landscape.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's stocks from the floor of the New York Stock Exchange.
RAD suffers not only from concerns that Amazon is taking business but it has no growth and is barely breaking even.
They pulled the plus on the Rite Aid-Alberstons merger ahead of the vote -- listen to Cramer react to that now!
The charts of Rite Aid have been stalled for months leading up to the Albertsons' merger falling through.
Amazon's acquisition of PillPack is hitting traditional pharmacies.
These are the stories to watch as stock futures fall Wednesday morning.
If anyone can sell it to antitrust regulators, T-Mobile CEO John Legere can.
The world remains dangerous, and dangerous toys are not just simply in demand -- demand is increasing rapidly.
Here's what you need to know today: U.S. stock futures rise modestly; Delta Air Lines and BlackRock report earnings; Facebook's value soars during Mark Zuckerberg's congressional testimony; and more. Watch now!
Better-than-expected earnings will help soothe market jitters in the second quarter.
For Women's History Month, Alpha Rising sat down with Nancy Lieberman, Of Counsel at Skadden, Arps. She was and still is the youngest person to ever make partner at her firm. She has worked on some of the biggest M&A deals in history -- and we should mention -- she's in a wheelchair and barely as use of her hands. Feel like a slacker yet? Good. Watch.
As Albertsons prepares to bring a significant piece of Rite Aid into its family, we took a look back at how the grocer became the mega chain it is today.
Walmart surprised many on Wall Street with its 2018 outlook, and not positively. Here's what's up.
Welcome back from the long weekend, Wall Street. Here's what you must know.